ICI response can be reduced by some genomic variations (eg, KEAP1, STK11),11 and are associated with microsatellite instability,12 neoantigen load,13 tumor-inflamed phenotypes,14 tumor-infiltrating lymphocytes (TILs),15 and tertiary lymphoid structures (TLS).16 The gene discussed is STK11; the disease is neoplasm.